MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--As Neutra Corp. (OTCBB: NTRR) and its partners continue to market and develop new products to serve the U.S. cannabis industry, a new report from analysts ArcView Market Research named that rapidly expanding industry as the fastest-growing in the country.
In its new publication, “State of Legal Marijuana Markets – 3rd Edition,” ArcView reports that the U.S. market for legal cannabis grew 74 percent in 2014 to $2.7 billion, up from $1.5 billion the year before. Such staggering growth has outpaced all other domestic industries, with more dramatic expansion forecast to come. ArcView predicts that over the next five years, 14 more states will legalize the plant for adult use.
“Interest and investment in the U.S. cannabis industry skyrocketed in 2014,” said NTRR CEO Chris Brown. “2015 is set to be even bigger. NTRR is hard at work bringing innovative new technologies to consumers and businesses in this space in order to carve out a share of this business for our company and expose our investors to this phenomenal growth opportunity.”
Last year, Oregon and Alaska become the third and fourth states to legalize recreational cannabis, which means cannabis stores could open in both states as soon as 2016. Proposals also passed allowing the possession of cannabis in Washington, D.C. and South Portland, Maine, and Guam became the first U.S. territory to approve medical cannabis.
This historic cannabis market expansion inspired NTRR to partner with up-and-coming innovators in a large ancillary market that is also benefiting from the fast-growing legalized cannabis industry. Alongside partners like Vertigo Technologies, Diamond Anvil Designs and Surface to Air Solutions, the company is working to deliver powerful, practical breakthroughs in the indoor cultivation and delivery of cannabis and other nutraceuticals.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.